The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy
Authors
Keywords
Lymphoma, Surrogate endpoint, Positron emission tomography
Journal
CANCER IMAGING
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-11-29
DOI
10.1186/s40644-014-0034-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone marrow18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma
- (2014) Hugo J.A. Adams et al. AMERICAN JOURNAL OF HEMATOLOGY
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study
- (2014) Maurizio Martelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement
- (2013) A. B. Khan et al. BLOOD
- FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis
- (2013) Hugo J. A. Adams et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy
- (2013) L. Berthet et al. JOURNAL OF NUCLEAR MEDICINE
- Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
- (2013) David Cunningham et al. LANCET
- Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial
- (2013) Richard Delarue et al. LANCET ONCOLOGY
- Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3–5 October 2012
- (2013) Michel Meignan et al. LEUKEMIA & LYMPHOMA
- Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era
- (2012) Deok-Hwan Yang et al. ANNALS OF HEMATOLOGY
- Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma
- (2012) Hiromitsu Daisaki et al. ANNALS OF NUCLEAR MEDICINE
- Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
- (2012) P. Pregno et al. BLOOD
- Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours
- (2012) Christophe Van de Wiele et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Links between metabolism and cancer
- (2012) C. V. Dang GENES & DEVELOPMENT
- Marked, Homogeneous, and Early [18F]Fluorodeoxyglucose–Positron Emission Tomography Responses to Vemurafenib in BRAF-Mutant Advanced Melanoma
- (2012) Grant A. McArthur et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of various criteria in interpreting end of therapy F-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography in patients with aggressive non-Hodgkin lymphoma
- (2012) Kuruva Manohar et al. LEUKEMIA & LYMPHOMA
- Fundamentals of PET and PET/CT imaging
- (2011) Sandip Basu et al. Annals of the New York Academy of Sciences
- SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
- (2011) R.-O. Casasnovas et al. BLOOD
- Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma
- (2011) Deok-Hwan Yang et al. EUROPEAN JOURNAL OF CANCER
- Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab
- (2011) Violaine Safar et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation
- (2011) A. F. Cashen et al. JOURNAL OF NUCLEAR MEDICINE
- Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP
- (2010) Changhoon Yoo et al. ANNALS OF HEMATOLOGY
- Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma
- (2010) Pier Luigi Zinzani et al. CANCER
- Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
- (2010) Sally F. Barrington et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
- (2010) Craig H. Moskowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments
- (2010) Josée M. Zijlstra et al. LEUKEMIA & LYMPHOMA
- Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study
- (2009) S. J. Horning et al. BLOOD
- Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy
- (2009) E. Itti et al. JOURNAL OF NUCLEAR MEDICINE
- Report on the First International Workshop on interim-PET scan in lymphoma
- (2009) Michel Meignan et al. LEUKEMIA & LYMPHOMA
- High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens
- (2008) H. S. Han et al. ANNALS OF ONCOLOGY
- The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
- (2008) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Reproducibility of Standardized Uptake Value Measurements Determined by 18F-FDG PET in Malignant Tumors
- (2008) C. Nahmias et al. JOURNAL OF NUCLEAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started